Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Design of a triplex fluorescence aptasensor for a culture-free diagnosis of peritoneal dialysis-related peritonitis.

Scientific reports·2026

Same author

Co-enrichment of proteins in extracellular vesicles.

Nature communications·2026

Same author

Development of a quality control test for diphtheria vaccine based on an electrochemical aptamer-based biosensor.

Scientific reports·2026

Same author

Corrections to: An aptamer-based fluorometric microcystin-LR assay using DNA strand-based competitive displacement.

Mikrochimica acta·2026

Same author

A Wearable Microneedle-Integrated Multiplexed Photonic Aptasensor for the Detection of Illicit Drugs in Interstitial Fluid.

Analytical chemistry·2026

Same author

Engineering Aptameric Responsive Photonic Biosensor Based on Cholesteric Liquid Crystal Network for the Detection of Anatoxin.

Analytical chemistry·2025

Search research articles

Related Experiment Video

Updated: May 17, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Wash-less and highly sensitive assay for prostate specific antigen detection.

Ghadeer A R Y Suaifan¹, Chiheb Esseghaier, Andy Ng

¹Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan.

|October 23, 2012

Summary

A new biosensor detects prostate-specific antigen (PSA) by measuring changes in electrical impedance after PSA cleaves magnetic bead substrates. This simple, label-free method offers a sensitive and cost-effective approach for PSA diagnostics.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Related Experiment Videos

Last Updated: May 17, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Area of Science:

Biomedical Engineering
Biosensor Technology
Electrochemistry

Background:

Prostate cancer is a significant health concern, necessitating accurate and accessible diagnostic tools.
Current prostate-specific antigen (PSA) detection methods can be complex and costly.
There is a need for simple, sensitive, and cost-effective biosensors for early PSA detection.

Purpose of the Study:

To develop a novel, simple, and facile electrochemical biosensor for prostate-specific antigen (PSA) detection.
To utilize the enzymatic activity of PSA for a label-free detection mechanism.
To assess the sensitivity, specificity, and potential for point-of-care application of the developed biosensor.

Main Methods:

Construction of a biosensor using magnetic carrier complexes functionalized with a PSA substrate.
Electrochemical analysis (impedance spectroscopy) to monitor the cleavage of the substrate by proteolytically active PSA.
Evaluation of sensor performance using varying concentrations of PSA and a negative control substrate.

Main Results:

The biosensor demonstrated a significant decrease in impedance signal upon PSA-induced substrate cleavage.
A positive impedance change was observed with a negative control, confirming the specificity of the detection.
The sensor accurately detected PSA concentrations from 1 pg/mL to 1 μg/mL, with a low detection limit of 1 pg/mL.

Conclusions:

A novel electrochemical biosensor for PSA detection has been successfully developed.
The biosensor exhibits high sensitivity, specificity, and a low detection limit, suitable for clinical diagnostics.
The wash-less, label-free, and cost-effective nature of the biosensor holds promise for developing point-of-care diagnostic devices.